# Novel Biomarkers of Preeclampsia, Aquaporin, Fatty Acid, and S110B

> **NCT03567551** · — · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 126 (actual)

## Conditions studied

- Preeclampsia

## Interventions

- **OTHER:** Women w/ Preeclampsia w/o Visual Disturbances or Headache
- **OTHER:** Women w/ Preeclampsia w/ Visual Disturbances or Headaches
- **OTHER:** Women w/o Preeclampsia

## Key facts

- **NCT ID:** NCT03567551
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-15
- **Primary completion:** 2020-01-13
- **Final completion:** 2021-09-15
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2022-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03567551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03567551, "Novel Biomarkers of Preeclampsia, Aquaporin, Fatty Acid, and S110B". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03567551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*